eu
-
Financial
Zimmer revises Biomet bid for EU regulators
February 10, 2015 by Brad Perriello Zimmer revises its $13 billion bid for crosstown rival Biomet in a further effort to mollify…
Read More » -
Financial
Zimmer Holdings (ZMH) Submits Remedy Package for EC Approval of Biomet Deal
Zimmer Holdings (NYSE: ZMH) announced that it has proposed a remedy package to the European Commission (the “EC”) to facilitate…
Read More » -
Financial
Medtronic offers EU concessions in $43 billion Covidien deal
(Reuters) – U.S. medical device maker Medtronic Inc (MDT.N) has offered concessions in a bid to secure European Union regulatory…
Read More » -
Recon
EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal: sources
(Reuters) – EU antitrust regulators will widen a probe into Zimmer Holdings Inc’s (ZMH.N) $13.4 billion bid for Biomet Inc…
Read More » -
Spine
Titan Spine Signs Distribution Agreement with Biomet for Endoskeleton® Interbody Fusion Devices in Europe
Initial Distribution in Germany, with Broader EU Distribution in Coming Months MEQUON, Wis.–(BUSINESS WIRE)–Titan Spine, a medical device surface technology…
Read More » -
Robotics
Mazor Robotics Announces Key European Patent for Renaissance(TM) Surgical Guidance Robot
CAESAREA, Israel, Jan 06, 2012 (BUSINESS WIRE) — Mazor Robotics Ltd. (tase:MZOR), a developer of innovative surgical robots and complementary…
Read More » -
Kuros Announces Allowance of European Patent for Synthetic Biomaterials
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound…
Read More »